Search Results
Honoring a Devoted UFCW “Cancer Kicker”
Frank Meehan spent two decades spearheading the United Food & Commercial Workers’ (UFCW) effort to raise money to defeat blood cancers. As president of the Long Island, NY Local, he was one of the first leaders to act upon the union’s national relationship with The Leukemia & Lymphoma Society (LLS).
Then last spring, in a twist of fate, he ended up losing his life to one of the aggressive leukemias he’d been hoping to see cured.
Procarbazine
Procarbazine is FDA approved with other anticancer drugs for the treatment of stage III and IV Hodgkin lymphoma. Procarbazine is used as part of the MOPP (mechlorethamine, Oncovin® [vincristine], procarbazine, prednisone) regimen. This medicine may cause a temporary loss of hair in some people. After treatment with procarbazine has ended, normal hair growth should return.
4 Perspectives on How Nonprofits Help
If you want to change the world, there’s more than one way to do it. You could start in your community, helping friends and neighbors. You could also turn to a nonprofit organization—as a volunteer, donor, advocate, or even by joining the staff—to widen your impact.
We know a lot of changemakers at The Leukemia & Lymphoma Society (LLS). Passionate, amazing people who work hard to help us make life better for blood cancer patients, survivors, and their families. They know that we can make the most progress toward a world without blood cancer together.
Surviving Chemo: A Little Planning Goes a Long Way
Just the thought of chemotherapy can be enough to make one feel sick. Toxic drugs powerful enough to kill or damage cancer cells also take their toll on healthy cells. While everyone tends to respond differently, most agree the treatments come with unpleasant side effects.
Check out these 14 tips from The Leukemia & Lymphoma Society that should help make the experience a little less uncomfortable:
Volunteers: The Engine Powering LLS’s Mission
I was always aware that volunteers with The Leukemia & Lymphoma Society (LLS) drive impact for blood cancer patients and families. But it wasn’t until Thanksgiving Day 2007 that I discovered the full force of their power. My wife, Holly, had recently been diagnosed with follicular lymphoma and our family was still reeling from the news. She was feeling quite ill, and we were exhausted with worry and trying to keep life as normal as possible for our two young children.
Cytarabine
Cytarabine is FDA approved to prevent and treat leukemia that has spread to the meninges (the three membranes that cover the brain and spinal cord). It is also FDA approved for use with other drugs to treat acute myeloid leukemia, acute lymphoblastic leukemia and chronic myeloid leukemia. This medicine may cause a temporary loss of hair in some people. After treatment with cytarabine has ended, normal hair growth should return.
Liposomal cytarabine (DepoCyt®) is given by intrathecal injection. It is FDA approved to treat lymphoma that has spread to the meninges.
Bortezomib
Bortezomib is FDA approved to treat people with myeloma and for the retreatment of adult patients with myeloma who had previously responded to bortezomib therapy and relapsed at least six months following completion of prior bortezomib treatment. Bortezomib is also approved to treat people with previously untreated mantle cell lymphoma as well as patients who have received at least one prior therapy.
Beat AML in the Time of COVID-19: A Powerful New Video
Like many clinical trials across the U.S. and the globe, The Leukemia & Lymphoma’s Beat AML Master Trial has been dramatically impacted by the COVID-19 pandemic and has had to make adjustments to continue to provide critical treatment to patients who were previously enrolled.
A Groundbreaking Trial